Navamedic ASA (NAVA.OL)
NOK 23.5
(7.31%)
NOK 23.5
(7.31%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.19 NOK | -89.14% |
| 2022 | 1.75 NOK | 4517.41% |
| 2021 | 0.04 NOK | 103.32% |
| 2020 | -1.14 NOK | 17.99% |
| 2019 | -1.39 NOK | -307.46% |
| 2018 | 0.67 NOK | 146.85% |
| 2017 | -1.43 NOK | -37.5% |
| 2016 | -1.04 NOK | 16.13% |
| 2015 | -1.24 NOK | -1451.94% |
| 2014 | -0.08 NOK | 46.73% |
| 2013 | -0.15 NOK | 62.5% |
| 2012 | -0.40 NOK | 57.89% |
| 2011 | -0.95 NOK | 35.81% |
| 2010 | -1.48 NOK | -187.06% |
| 2009 | 1.70 NOK | 258.88% |
| 2008 | -1.07 NOK | -109.8% |
| 2007 | -0.51 NOK | 61.65% |
| 2006 | -1.33 NOK | -22.02% |
| 2005 | -1.09 NOK | -192.37% |
| 2004 | 1.18 NOK | 972.73% |
| 2003 | 0.11 NOK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.15 NOK | -87.18% |
| 2024 Q2 | 1.17 NOK | 1382.89% |
| 2024 Q1 | -0.09 NOK | -83.87% |
| 2023 Q3 | 0.39 NOK | 142.39% |
| 2023 Q2 | -0.92 NOK | -219.48% |
| 2023 Q1 | 0.77 NOK | -34.19% |
| 2023 Q4 | -0.05 NOK | -112.72% |
| 2023 FY | - NOK | -89.14% |
| 2022 FY | - NOK | 4517.41% |
| 2022 Q4 | 1.17 NOK | 680.0% |
| 2022 Q3 | 0.15 NOK | -65.91% |
| 2022 Q2 | 0.44 NOK | 1118.52% |
| 2022 Q1 | -0.04 NOK | -122.74% |
| 2021 Q3 | -0.12 NOK | -160.0% |
| 2021 FY | - NOK | 103.32% |
| 2021 Q1 | -0.22 NOK | 33.33% |
| 2021 Q4 | 0.19 NOK | 258.33% |
| 2021 Q2 | 0.20 NOK | 190.91% |
| 2020 Q2 | 0.04 NOK | 104.04% |
| 2020 FY | - NOK | 17.99% |
| 2020 Q4 | -0.33 NOK | -1962.5% |
| 2020 Q3 | -0.02 NOK | -143.01% |
| 2020 Q1 | -0.92 NOK | 0.0% |
| 2019 Q3 | -0.21 NOK | 44.74% |
| 2019 Q4 | -0.92 NOK | -338.1% |
| 2019 FY | - NOK | -307.46% |
| 2019 Q1 | -0.14 NOK | -112.28% |
| 2019 Q2 | -0.38 NOK | -171.43% |
| 2018 FY | - NOK | 146.85% |
| 2018 Q4 | 1.14 NOK | 860.0% |
| 2018 Q3 | -0.15 NOK | -850.0% |
| 2018 Q2 | 0.02 NOK | 102.99% |
| 2018 Q1 | -0.67 NOK | 17.28% |
| 2017 Q1 | -0.25 NOK | -143.86% |
| 2017 Q4 | -0.81 NOK | -285.71% |
| 2017 Q3 | -0.21 NOK | -536.59% |
| 2017 FY | - NOK | -37.5% |
| 2017 Q2 | 0.05 NOK | 119.24% |
| 2016 Q2 | -1.34 NOK | -204.55% |
| 2016 Q3 | -0.11 NOK | 91.79% |
| 2016 Q1 | -0.44 NOK | 64.52% |
| 2016 FY | - NOK | 16.13% |
| 2016 Q4 | 0.57 NOK | 618.18% |
| 2015 Q1 | 0.18 NOK | 346.91% |
| 2015 Q4 | -1.24 NOK | -416.67% |
| 2015 Q2 | 0.09 NOK | -50.44% |
| 2015 FY | - NOK | -1451.94% |
| 2015 Q3 | -0.24 NOK | -369.06% |
| 2014 Q1 | 0.00 NOK | 100.73% |
| 2014 FY | - NOK | 46.73% |
| 2014 Q4 | -0.07 NOK | -140.5% |
| 2014 Q3 | 0.18 NOK | 260.72% |
| 2014 Q2 | 0.05 NOK | 4436.36% |
| 2013 Q4 | -0.15 NOK | -36.36% |
| 2013 FY | - NOK | 62.5% |
| 2013 Q1 | 0.17 NOK | 473.63% |
| 2013 Q2 | -0.06 NOK | -134.53% |
| 2013 Q3 | -0.11 NOK | -87.39% |
| 2012 FY | - NOK | 57.89% |
| 2012 Q4 | -0.05 NOK | 74.72% |
| 2012 Q3 | -0.18 NOK | -283.8% |
| 2012 Q1 | -0.14 NOK | 33.33% |
| 2012 Q2 | -0.05 NOK | 66.5% |
| 2011 Q1 | -0.24 NOK | 56.36% |
| 2011 Q3 | -0.27 NOK | -22.73% |
| 2011 Q2 | -0.22 NOK | 8.33% |
| 2011 Q4 | -0.21 NOK | 22.22% |
| 2011 FY | - NOK | 35.81% |
| 2010 FY | - NOK | -187.06% |
| 2010 Q4 | -0.55 NOK | -61.76% |
| 2010 Q1 | -0.28 NOK | -255.56% |
| 2010 Q2 | -0.32 NOK | -14.29% |
| 2010 Q3 | -0.34 NOK | -6.25% |
| 2009 FY | - NOK | 258.88% |
| 2009 Q4 | 0.18 NOK | -55.0% |
| 2009 Q3 | 0.40 NOK | 176.92% |
| 2009 Q2 | -0.52 NOK | -300.0% |
| 2009 Q1 | -0.13 NOK | 0.0% |
| 2008 FY | - NOK | -109.8% |
| 2007 FY | - NOK | 61.65% |
| 2006 FY | - NOK | -22.02% |
| 2005 FY | - NOK | -192.37% |
| 2004 FY | - NOK | 972.73% |
| 2003 FY | - NOK | 0.0% |
| Name | Eps | Eps Difference |
|---|